LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.88 | 84.90 | 804 | 531 | 1.5141 | 1.3396 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.88 | 84.90 | 10 | 531 | 0.0188 | -0.5546 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.88 | 84.90 | 1057 | 531 | 1.9906 | 1.5946 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.58 | 84.90 | 5 | 663 | 0.0075 | -0.6151 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.58 | 84.90 | 845 | 663 | 1.2737 | 1.1700 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.58 | 84.90 | 10 | 663 | 0.0151 | -0.5138 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.58 | 84.90 | 1087 | 663 | 1.6385 | 1.3623 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.29 | 84.90 | 9 | 766 | 0.0117 | -0.5068 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.29 | 84.90 | 876 | 766 | 1.1423 | 1.0856 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.29 | 84.90 | 18 | 766 | 0.0235 | -0.3865 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.29 | 84.90 | 1091 | 766 | 1.4227 | 1.2349 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 17.99 | 84.90 | 9 | 898 | 0.0100 | -0.4827 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 17.99 | 84.90 | 890 | 898 | 0.9900 | 0.9941 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 17.99 | 84.90 | 32 | 898 | 0.0356 | -0.2492 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 17.99 | 84.90 | 1105 | 898 | 1.2292 | 1.1250 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 19.69 | 84.90 | 9 | 1239 | 0.0073 | -0.4402 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 19.69 | 84.90 | 891 | 1239 | 0.7189 | 0.8364 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 19.69 | 84.90 | 35 | 1239 | 0.0282 | -0.2047 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 19.69 | 84.90 | 1139 | 1239 | 0.9190 | 0.9568 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 21.40 | 84.90 | 8 | 1454 | 0.0055 | -0.4380 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 21.40 | 84.90 | 915 | 1454 | 0.6290 | 0.7861 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 21.40 | 84.90 | 42 | 1454 | 0.0289 | -0.1578 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 21.40 | 84.90 | 1165 | 1454 | 0.8009 | 0.8945 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 23.10 | 84.90 | 10 | 1616 | 0.0062 | -0.3954 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 23.10 | 84.90 | 942 | 1616 | 0.5828 | 0.7615 | MN20160318_Q02 | F13 |